108(top 100%)
papers
14.5K(top 1%)
citations
37(top 100%)
h-index
110(top 100%)
g-index
131
all documents
16.1K
doc citations
2.4K
citing journals
100
times ranked

Publications

122 papers • 16,133 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Sex-specific Associations of Aldosterone and Renin With Body Composition: A Population-based Cohort Study4.54Citations (PDF)
2Damage-Associated Molecular Patterns and Pattern Recognition Receptors in the Podocyte0.33Citations (PDF)
3Unraveling the molecular landscape of kAE1: a narrative review1.90Citations (PDF)
4miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction
Clinical Science, 2024, 138, 599-614
6.38Citations (PDF)
5Systematic review of microRNAs in human acute kidney injury
Renal Failure, 2024, 46,
2.66Citations (PDF)
6Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension
Cardiovascular Research, 2023, 119, 381-409
5.6113Citations (PDF)
7The Proteome of Circulating Large Extracellular Vesicles in Diabetes and Hypertension4.55Citations (PDF)
8The Influence of Exercise-Associated Small Extracellular Vesicles on Trophoblasts In Vitro
Biomedicines, 2023, 11, 857
3.64Citations (PDF)
9Urinary podocyte-derived large extracellular vesicles are increased in paediatric idiopathic nephrotic syndrome0.810Citations (PDF)
10The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
Cancers, 2023, 15, 2566
4.114Citations (PDF)
11Annexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding
Pharmaceuticals, 2023, 16, 837
4.410Citations (PDF)
12Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review
Cytotherapy, 2023, 25, 939-945
0.654Citations (PDF)
13Direct mapping of kidney function by DCE-MRI urography using a tetrazinanone organic radical contrast agent14.29Citations (PDF)
14Urinary Extracellular Vesicles in Urology: Current Successes and Challenges Ahead1.40Citations (PDF)
15Extracellular Vesicles as Novel Players in Kidney Disease0.311Citations (PDF)
16Phosphate and Endothelial Function: How Sensing of Elevated Inorganic Phosphate Concentration Generates Signals in Endothelial Cells8.02Citations (PDF)
17Extracellular vesicles in gestational diabetes mellitus: A scoping review2.816Citations (PDF)
18Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy
PLoS ONE, 2022, 17, e0264136
2.513Citations (PDF)
19Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
Cancers, 2022, 14, 1039
4.124Citations (PDF)
20Pulmonary and Neurologic Effects of Mesenchymal Stromal Cell Extracellular Vesicles in a Multifactorial Lung Injury Model9.329Citations (PDF)
21A letter to the editor about “dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis”
Experimental Cell Research, 2022, 415, 113065
3.20Citations (PDF)
22Urinary interleukin-9 in youth with type 1 diabetes mellitus
Acta Diabetologica, 2022, 59, 939-947
2.311Citations (PDF)
23Can Peer Review Be Kinder? Supportive Peer Review: A Re-Commitment to Kindness and a Call to Action1.39Citations (PDF)
24Extracellular Vesicles as an Index for Endothelial Injury and Cardiac Dysfunction in a Rodent Model of GDM4.55Citations (PDF)
25Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health2.111Citations (PDF)
26Reduction of DUSP4 contributes to podocytes oxidative stress, insulin resistance and diabetic nephropathy2.110Citations (PDF)
27Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation4.54Citations (PDF)
28Exploring Urinary Extracellular Vesicles and Immune Mediators as Biomarkers of Kidney Injury in COVID-19 Hospitalized Patients
Diagnostics, 2022, 12, 2600
3.39Citations (PDF)
29Advancing Discovery Research in Nephrology in Canada: A Conference Report From the 2021 Molecules and Mechanisms Mediating Kidney Health and Disease (M3K) Scientific Meeting and Investigator Summit1.30Citations (PDF)
30Evaluation of Circulating Platelet Extracellular Vesicles and Hypertension Mediated Organ Damage4.51Citations (PDF)
31Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
Diabetes Care, 2021, 44, e45-e47
9.632Citations (PDF)
32MicroRNA in Human Acute Kidney Injury: A Systematic Review Protocol1.34Citations (PDF)
33Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension
BMJ Open, 2021, 11, e043625
2.011Citations (PDF)
34Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?
Diabetologia, 2021, 64, 1527-1537
7.59Citations (PDF)
35Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles13.0318Citations (PDF)
36Accumulation of Seminolipid in Sertoli Cells Is Associated with Increased Levels of Reactive Oxygen Species and Male Subfertility: Studies in Aging Arsa Null Male Mice
Antioxidants, 2021, 10, 912
5.814Citations (PDF)
37Circulating small extracellular vesicles increase after an acute bout of moderate-intensity exercise in pregnant compared to non-pregnant women
Scientific Reports, 2021, 11,
3.714Citations (PDF)
38Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation
Hypertension, 2021, 77, 1825-1844
6.351Citations (PDF)
39Diastolic hypertension is associated with proteinuria in pediatric patients1.92Citations (PDF)
40Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes
Kidney International Reports, 2021, 6, 2095-2104
0.838Citations (PDF)
41Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial9.35Citations (PDF)
42Relapse in steroid-sensitive nephrotic syndrome: are extracellular vesicles the missing link?3.43Citations (PDF)
43A standarized protocol for evaluation of large extracellular vesicles using the attune™ NXT system1.58Citations (PDF)
44Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application3.696Citations (PDF)
45The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
Oncogene, 2020, 39, 1600-1616
6.7119Citations (PDF)
46May Measurement Month 2018: results of blood pressure screening from 41 countries0.37Citations (PDF)
47An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use
ACS Nano, 2020, 14, 9728-9743
15.4107Citations (PDF)
48Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice
Nature Neuroscience, 2020, 23, 1090-1101
18.2106Citations (PDF)
49May Measurement Month 2019
Hypertension, 2020, 76, 333-341
6.3227Citations (PDF)
50Intact Viral Particle Counts Measured by Flow Virometry Provide Insight into the Infectivity and Genome Packaging Efficiency of Moloney Murine Leukemia Virus3.628Citations (PDF)
51Hypertension and vascular alterations in lupus autoimmunity
Journal of Hypertension, 2020, 38, 1257-1258
0.61Citations (PDF)
52Plasma Gelsolin Inhibits CD8+ T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian Cancer
Cancer Research, 2020, 80, 3959-3971
0.655Citations (PDF)
53Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes
Diabetologia, 2020, 64, 469-475
7.514Citations (PDF)
54Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature3.925Citations (PDF)
55Extracellular Vesicles: Cell-Derived Biomarkers of Glomerular and Tubular Injury1.335Citations (PDF)
56Highlights from the International Society of Hypertension's New Investigators Network during 2019
Journal of Hypertension, 2020, 38, 968-973
0.61Citations (PDF)
57Effect of hemodialysis on extracellular vesicles and circulating submicron particles
BMC Nephrology, 2019, 20,
2.227Citations (PDF)
58Microparticles and Exosomes in Cell-Cell Communication
2019, , 159-168
1Citations (PDF)
59PBI-4050 via GPR40 activation improves adenine-induced kidney injury in mice
Clinical Science, 2019, 133, 1587-1602
6.314Citations (PDF)
60Prostaglandin E2 receptor EP1 (PGE2/EP1) deletion promotes glomerular podocyte and endothelial cell injury in hypertensive TTRhRen mice
Laboratory Investigation, 2019, 100, 414-425
3.712Citations (PDF)
61183-OR: Placental Growth Factor and Fetal Growth in Women with Type 1 Diabetes Mellitus
Diabetes, 2019, 68,
0.50Citations (PDF)
62Thyroid-Stimulating Hormone-Stimulated Human Adipocytes Express Thymic Stromal Lymphopoietin1.84Citations (PDF)
63Podocyte‐derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD3613.085Citations (PDF)
64A11518 Hemodialysis reduces levels of circulating microparticles in individuals with hypertension
Journal of Hypertension, 2018, 36, e202-e203
0.60Citations (PDF)
65Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines13.09,284Citations (PDF)
66Receptor-Ligand Interaction Mediates Targeting of Endothelial Colony Forming Cell-derived Exosomes to the Kidney after Ischemic Injury3.788Citations (PDF)
67TSH Increases Platelet Microparticles in vivo and Stimulates Adipocyte-Derived TSLP Production in vitro0.80Citations (PDF)
68High glucose increases the formation and pro-oxidative activity of endothelial microparticles
Diabetologia, 2017, 60, 1791-1800
7.593Citations (PDF)
69Survival Motor Neuron Protein is Released from Cells in Exosomes: A Potential Biomarker for Spinal Muscular Atrophy3.719Citations (PDF)
70Microparticle Formation in Peritoneal Dialysis1.39Citations (PDF)
71Single-Particle Discrimination of Retroviruses from Extracellular Vesicles by Nanoscale Flow Cytometry3.738Citations (PDF)
72Endothelial Microparticle‐Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function4.563Citations (PDF)
73Protein Kinase C-δ Mediates Shedding of Angiotensin-Converting Enzyme 2 from Proximal Tubular Cells4.014Citations (PDF)
74OS 02-03 EFFECT OF HIGH GLUCOSE EXPOSURE ON ENDOTHELIAL MICROPARTICLE FORMATION AND COMPOSITION0.62Citations (PDF)
75A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
Lancet, The, 2016, 388, 2665-2712
14.8841Citations (PDF)
76Transfer of microRNA-486-5p from human endothelial colony forming cell–derived exosomes reduces ischemic kidney injury
Kidney International, 2016, 90, 1238-1250
5.3206Citations (PDF)
77Effect of High Glucose Exposure on Endothelial Microparticle Formation and CompositionImage 40.70Citations (PDF)
78Assessment of urinary microparticles in normotensive patients with type 1 diabetes
Diabetologia, 2016, 60, 581-584
7.572Citations (PDF)
79Across the globe in 4 months
Journal of Hypertension, 2015, 33, 891-893
0.61Citations (PDF)
80Thyroid‐stimulating hormone acutely increases levels of circulating pro‐coagulant microparticles
Clinical Endocrinology, 2015, 83, 285-287
2.58Citations (PDF)
81Human Endothelial Colony-Forming Cells Protect against Acute Kidney Injury
American Journal of Pathology, 2015, 185, 2309-2323
3.5210Citations (PDF)
82Re: Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI
Kidney International, 2015, 88, 915
5.31Citations (PDF)
83Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors
Laboratory Investigation, 2015, 95, 1044-1055
3.716Citations (PDF)
84Acute Kidney Injury: Preclinical Innovations, Challenges, and Opportunities for Translation1.325Citations (PDF)
85A Novel Mouse Model of Advanced Diabetic Kidney Disease
PLoS ONE, 2014, 9, e113459
2.539Citations (PDF)
86Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension
Clinical Science, 2014, 127, 57-63
6.330Citations (PDF)
87Microparticles generated during chronic cerebral ischemia deliver proapoptotic signals to cultured endothelial cells2.121Citations (PDF)
88Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular Injury0.3130Citations (PDF)
89Report of the 3rd Annual International Society Of Hypertension New Investigator Symposium
Journal of Hypertension, 2014, 32, 448-449
0.61Citations (PDF)
90Microparticles: biomarkers and beyond
Clinical Science, 2013, 124, 423-441
6.3321Citations (PDF)
91Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature6.4411Citations (PDF)
92‘Shedding’ light on mechanisms of hyperphosphatemic vascular dysfunction
Kidney International, 2013, 83, 187-189
5.315Citations (PDF)
93Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
Clinical Science, 2013, 124, 191-202
6.3150Citations (PDF)
94Leading the change
Journal of Hypertension, 2013, 31, 429-430
0.61Citations (PDF)
95Biomarkers in Hypertension
2012, , 237-246
4Citations (PDF)
96Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice0.818Citations (PDF)
97Microparticles Induce Cell Cycle Arrest Through Redox‐Sensitive Processes in Endothelial Cells: Implications in Vascular Senescence4.390Citations (PDF)
98Council for High Blood Pressure Research/InterAmerican Society of Hypertension/International Society of Hypertension: First New Investigators Symposium at the High Blood Pressure Research 2011 Scientific Sessions
Hypertension, 2012, 59, 382-383
6.32Citations (PDF)
99Report of the first International Society of Hypertension (ISH) Trainee/New Investigator Symposium
Journal of Hypertension, 2012, 30, 631-632
0.61Citations (PDF)
100Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells2.1187Citations (PDF)
101Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways
Hypertension, 2012, 59, 1069-1078
6.3346Citations (PDF)
102Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts5.4199Citations (PDF)
103ISH Hypertension Future Leaders Group
Journal of Hypertension, 2011, 29, 1664-1665
0.64Citations (PDF)
104Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5
Clinical Science, 2011, 120, 131-141
6.3101Citations (PDF)
105NOX Isoforms and Reactive Oxygen Species in Vascular Health3.4107Citations (PDF)
106Angiotensin II and the vascular phenotype in hypertension5.0175Citations (PDF)
107Protective Role of Nitric Oxide Against Cardiac Arrhythmia - An Update0.45Citations (PDF)
108New insights into molecular mechanisms of hypertension2.43Citations (PDF)
109Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 (Nox5) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium/Calmodulin-Dependent, Rac-1-Independent Pathways in Human Endothelial Cells
Circulation Research, 2010, 106, 1363-1373
11.3181Citations (PDF)
110Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM7 Modulation by Magnesium
Hypertension, 2010, 56, 453-462
6.3205Citations (PDF)
111Molecular Basis of Cardioprotection by Erythropoietin1.853Citations (PDF)
112Neuronal Nitric Oxide Synthase Protects Against Myocardial Infarction-Induced Ventricular Arrhythmia and Mortality in Mice
Circulation, 2009, 120, 1345-1354
10.1117Citations (PDF)
113Tissue inhibitor of metalloproteinase-3 inhibits neonatal mouse cardiomyocyte proliferation via EGFR/JNK/SP-1 signaling4.440Citations (PDF)
114Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion3.943Citations (PDF)
115Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase3.533Citations (PDF)
116Microvascular oxygen transport in obese ZDF rats: an early model of type II diabetes
FASEB Journal, 2008, 22,
0.70Citations (PDF)
117Role of neuronal nitric oxide synthase in lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal mouse cardiomyocytes
Cardiovascular Research, 2007, 75, 408-416
5.624Citations (PDF)
118Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase
Cardiovascular Research, 2006, 72, 51-59
5.6139Citations (PDF)
119Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation4.431Citations (PDF)
120GSK‐3b inactivation in preventing the myocardium from I/R‐induced injury: Role of eNOS‐derived NO
FASEB Journal, 2006, 20,
0.70Citations (PDF)
121Erythropoietin Inhibits Anoxia/Reoxygenation‐Induced Cardiomyocyte Apoptosis via Heme Oxygenase‐1
FASEB Journal, 2006, 20,
0.70Citations (PDF)
122Hot off the Press: Effector CD4+ cells recognize intravascular antigen presented by patrolling monocytes0.00Citations (PDF)